Dolby Laboratories, Inc. (NYSE: DLB) Stock Competitors & Peer Comparison

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, IBM has a market cap of 213.5B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while IBM trades at $226.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas IBM's P/E ratio is 19.08. In terms of profitability, DLB's ROE is +0.09%, compared to IBM's ROE of +0.34%. Regarding short-term risk, DLB is less volatile compared to IBM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check IBM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, ACN has a market cap of 106B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while ACN trades at $173.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas ACN's P/E ratio is 12.65. In terms of profitability, DLB's ROE is +0.09%, compared to ACN's ROE of +0.25%. Regarding short-term risk, DLB is less volatile compared to ACN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ACN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, INFY has a market cap of 51.3B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while INFY trades at $12.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas INFY's P/E ratio is 15.23. In terms of profitability, DLB's ROE is +0.09%, compared to INFY's ROE of +0.33%. Regarding short-term risk, DLB is less volatile compared to INFY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check INFY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, FI has a market cap of 34.3B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while FI trades at $63.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas FI's P/E ratio is 9.86. In terms of profitability, DLB's ROE is +0.09%, compared to FI's ROE of +0.13%. Regarding short-term risk, DLB is less volatile compared to FI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check FI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, FISV has a market cap of 29.7B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while FISV trades at $55.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas FISV's P/E ratio is 8.60. In terms of profitability, DLB's ROE is +0.09%, compared to FISV's ROE of +0.13%. Regarding short-term risk, DLB is less volatile compared to FISV. This indicates lower risk in terms of short-term price fluctuations for DLB.Check FISV's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CTSH has a market cap of 26.5B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CTSH trades at $55.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CTSH's P/E ratio is 10.27. In terms of profitability, DLB's ROE is +0.09%, compared to CTSH's ROE of +0.15%. Regarding short-term risk, DLB is less volatile compared to CTSH. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CTSH's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, FIS has a market cap of 24.2B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while FIS trades at $46.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas FIS's P/E ratio is 7.92. In terms of profitability, DLB's ROE is +0.09%, compared to FIS's ROE of +0.18%. Regarding short-term risk, DLB is less volatile compared to FIS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check FIS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, WIT has a market cap of 19.4B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while WIT trades at $1.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas WIT's P/E ratio is 13.51. In terms of profitability, DLB's ROE is +0.09%, compared to WIT's ROE of +0.15%. Regarding short-term risk, DLB is less volatile compared to WIT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check WIT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CDW has a market cap of 18.9B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CDW trades at $147.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CDW's P/E ratio is 14.56. In terms of profitability, DLB's ROE is +0.09%, compared to CDW's ROE of +0.42%. Regarding short-term risk, DLB is less volatile compared to CDW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CDW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, BR has a market cap of 18.4B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while BR trades at $159.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas BR's P/E ratio is 16.99. In terms of profitability, DLB's ROE is +0.09%, compared to BR's ROE of +0.40%. Regarding short-term risk, DLB is less volatile compared to BR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, GIB has a market cap of 16.2B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while GIB trades at $74.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas GIB's P/E ratio is 11.98. In terms of profitability, DLB's ROE is +0.09%, compared to GIB's ROE of +0.17%. Regarding short-term risk, DLB is less volatile compared to GIB. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GIB's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, LDOS has a market cap of 14.4B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while LDOS trades at $114.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas LDOS's P/E ratio is 9.41. In terms of profitability, DLB's ROE is +0.09%, compared to LDOS's ROE of +0.29%. Regarding short-term risk, DLB is less volatile compared to LDOS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check LDOS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, AUR has a market cap of 11.7B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while AUR trades at $5.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas AUR's P/E ratio is -13.29. In terms of profitability, DLB's ROE is +0.09%, compared to AUR's ROE of -0.40%. Regarding short-term risk, DLB is less volatile compared to AUR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check AUR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, JKHY has a market cap of 11.4B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while JKHY trades at $161.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas JKHY's P/E ratio is 22.54. In terms of profitability, DLB's ROE is +0.09%, compared to JKHY's ROE of +0.24%. Regarding short-term risk, DLB is less volatile compared to JKHY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check JKHY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CACI has a market cap of 10.8B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CACI trades at $487.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CACI's P/E ratio is 16.66. In terms of profitability, DLB's ROE is +0.09%, compared to CACI's ROE of +0.13%. Regarding short-term risk, DLB is less volatile compared to CACI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CACI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, AUROW has a market cap of 10.6B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while AUROW trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas AUROW's P/E ratio is -0.41. In terms of profitability, DLB's ROE is +0.09%, compared to AUROW's ROE of -0.40%. Regarding short-term risk, DLB is less volatile compared to AUROW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check AUROW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, IREN has a market cap of 10.5B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while IREN trades at $29.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas IREN's P/E ratio is -20.35. In terms of profitability, DLB's ROE is +0.09%, compared to IREN's ROE of +0.03%. Regarding short-term risk, DLB is less volatile compared to IREN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check IREN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, INGM has a market cap of 7B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while INGM trades at $30.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas INGM's P/E ratio is 9.90. In terms of profitability, DLB's ROE is +0.09%, compared to INGM's ROE of +0.09%. Regarding short-term risk, DLB is less volatile compared to INGM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check INGM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, APLD has a market cap of 6.6B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while APLD trades at $23.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas APLD's P/E ratio is -33.17. In terms of profitability, DLB's ROE is +0.09%, compared to APLD's ROE of -0.17%. Regarding short-term risk, DLB is less volatile compared to APLD. This indicates lower risk in terms of short-term price fluctuations for DLB.Check APLD's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, G has a market cap of 6.2B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while G trades at $36.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas G's P/E ratio is 9.66. In terms of profitability, DLB's ROE is +0.09%, compared to G's ROE of +0.22%. Regarding short-term risk, DLB is less volatile compared to G. This indicates lower risk in terms of short-term price fluctuations for DLB.Check G's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, GDS has a market cap of 5.8B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while GDS trades at $29.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas GDS's P/E ratio is 11.93. In terms of profitability, DLB's ROE is +0.09%, compared to GDS's ROE of +0.10%. Regarding short-term risk, DLB is less volatile compared to GDS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GDS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, EPAM has a market cap of 5.6B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while EPAM trades at $106.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas EPAM's P/E ratio is 8.93. In terms of profitability, DLB's ROE is +0.09%, compared to EPAM's ROE of +0.11%. Regarding short-term risk, DLB is less volatile compared to EPAM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check EPAM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, EXLS has a market cap of 5.5B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while EXLS trades at $35.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas EXLS's P/E ratio is 17.60. In terms of profitability, DLB's ROE is +0.09%, compared to EXLS's ROE of +0.27%. Regarding short-term risk, DLB is less volatile compared to EXLS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check EXLS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, SAIC has a market cap of 4.9B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while SAIC trades at $117.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas SAIC's P/E ratio is 10.50. In terms of profitability, DLB's ROE is +0.09%, compared to SAIC's ROE of +0.27%. Regarding short-term risk, DLB is less volatile compared to SAIC. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SAIC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, PAY has a market cap of 4.6B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while PAY trades at $36.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas PAY's P/E ratio is 50.28. In terms of profitability, DLB's ROE is +0.09%, compared to PAY's ROE of +0.13%. Regarding short-term risk, DLB is less volatile compared to PAY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check PAY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, PSN has a market cap of 4.3B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while PSN trades at $40.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas PSN's P/E ratio is 12.69. In terms of profitability, DLB's ROE is +0.09%, compared to PSN's ROE of +0.09%. Regarding short-term risk, DLB is less volatile compared to PSN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check PSN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, NCR has a market cap of 3.8B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while NCR trades at $27.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas NCR's P/E ratio is 49.24. In terms of profitability, DLB's ROE is +0.09%, compared to NCR's ROE of +0.09%. Regarding short-term risk, DLB is less volatile compared to NCR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NCR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, NIQ has a market cap of 3.5B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while NIQ trades at $11.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas NIQ's P/E ratio is 33.25. In terms of profitability, DLB's ROE is +0.09%, compared to NIQ's ROE of -0.59%. Regarding short-term risk, DLB is less volatile compared to NIQ. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NIQ's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, WNS has a market cap of 3.3B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while WNS trades at $76.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas WNS's P/E ratio is 21.36. In terms of profitability, DLB's ROE is +0.09%, compared to WNS's ROE of +0.09%. Regarding short-term risk, DLB is more volatile compared to WNS. This indicates higher risk in terms of short-term price fluctuations for DLB.Check WNS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, KD has a market cap of 3.1B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while KD trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas KD's P/E ratio is 9.67. In terms of profitability, DLB's ROE is +0.09%, compared to KD's ROE of +0.16%. Regarding short-term risk, DLB is less volatile compared to KD. This indicates lower risk in terms of short-term price fluctuations for DLB.Check KD's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, PRFT has a market cap of 2.7B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while PRFT trades at $75.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas PRFT's P/E ratio is 36.34. In terms of profitability, DLB's ROE is +0.09%, compared to PRFT's ROE of +0.21%. Regarding short-term risk, DLB is more volatile compared to PRFT. This indicates higher risk in terms of short-term price fluctuations for DLB.Check PRFT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, NYAX has a market cap of 2.5B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while NYAX trades at $68.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas NYAX's P/E ratio is 106.25. In terms of profitability, DLB's ROE is +0.09%, compared to NYAX's ROE of +0.14%. Regarding short-term risk, DLB is more volatile compared to NYAX. This indicates higher risk in terms of short-term price fluctuations for DLB.Check NYAX's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, DXC has a market cap of 1.9B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while DXC trades at $11.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas DXC's P/E ratio is 3.62. In terms of profitability, DLB's ROE is +0.09%, compared to DXC's ROE of +0.01%. Regarding short-term risk, DLB is less volatile compared to DXC. This indicates lower risk in terms of short-term price fluctuations for DLB.Check DXC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, INOD has a market cap of 1.8B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while INOD trades at $55.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas INOD's P/E ratio is 49.91. In terms of profitability, DLB's ROE is +0.09%, compared to INOD's ROE of +0.37%. Regarding short-term risk, DLB is less volatile compared to INOD. This indicates lower risk in terms of short-term price fluctuations for DLB.Check INOD's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, VNET has a market cap of 1.8B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while VNET trades at $6.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas VNET's P/E ratio is -5.28. In terms of profitability, DLB's ROE is +0.09%, compared to VNET's ROE of -0.40%. Regarding short-term risk, DLB is less volatile compared to VNET. This indicates lower risk in terms of short-term price fluctuations for DLB.Check VNET's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, FORTY has a market cap of 1.7B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while FORTY trades at $108.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas FORTY's P/E ratio is 25.74. In terms of profitability, DLB's ROE is +0.09%, compared to FORTY's ROE of +0.59%. Regarding short-term risk, DLB is more volatile compared to FORTY. This indicates higher risk in terms of short-term price fluctuations for DLB.Check FORTY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, GLOB has a market cap of 1.6B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while GLOB trades at $38.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas GLOB's P/E ratio is 6.25. In terms of profitability, DLB's ROE is +0.09%, compared to GLOB's ROE of +0.05%. Regarding short-term risk, DLB is less volatile compared to GLOB. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GLOB's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CNXC has a market cap of 1.6B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CNXC trades at $26.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CNXC's P/E ratio is 2.42. In terms of profitability, DLB's ROE is +0.09%, compared to CNXC's ROE of -0.42%. Regarding short-term risk, DLB is less volatile compared to CNXC. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CNXC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, TWKS has a market cap of 1.4B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while TWKS trades at $4.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas TWKS's P/E ratio is -12.08. In terms of profitability, DLB's ROE is +0.09%, compared to TWKS's ROE of -0.09%. Regarding short-term risk, DLB is more volatile compared to TWKS. This indicates higher risk in terms of short-term price fluctuations for DLB.Check TWKS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, MGRT has a market cap of 1.4B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while MGRT trades at $96.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas MGRT's P/E ratio is 599.94. In terms of profitability, DLB's ROE is +0.09%, compared to MGRT's ROE of +0.21%. Regarding short-term risk, DLB is less volatile compared to MGRT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check MGRT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CLVT has a market cap of 1.4B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CLVT trades at $2.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CLVT's P/E ratio is 2.90. In terms of profitability, DLB's ROE is +0.09%, compared to CLVT's ROE of -0.03%. Regarding short-term risk, DLB is less volatile compared to CLVT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CLVT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, AI has a market cap of 1.3B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while AI trades at $8.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas AI's P/E ratio is -6.56. In terms of profitability, DLB's ROE is +0.09%, compared to AI's ROE of -0.64%. Regarding short-term risk, DLB is less volatile compared to AI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check AI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, BTCM has a market cap of 1.3B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while BTCM trades at $1.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas BTCM's P/E ratio is -0.53. In terms of profitability, DLB's ROE is +0.09%, compared to BTCM's ROE of -0.32%. Regarding short-term risk, DLB is less volatile compared to BTCM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BTCM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, BBAI has a market cap of 1.2B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while BBAI trades at $2.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas BBAI's P/E ratio is -3.78. In terms of profitability, DLB's ROE is +0.09%, compared to BBAI's ROE of -0.51%. Regarding short-term risk, DLB is less volatile compared to BBAI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BBAI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, VYX has a market cap of 1.2B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while VYX trades at $8.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas VYX's P/E ratio is 9.51. In terms of profitability, DLB's ROE is +0.09%, compared to VYX's ROE of +0.06%. Regarding short-term risk, DLB is less volatile compared to VYX. This indicates lower risk in terms of short-term price fluctuations for DLB.Check VYX's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, SIFY has a market cap of 1B. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while SIFY trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas SIFY's P/E ratio is 0.01. In terms of profitability, DLB's ROE is +0.09%, compared to SIFY's ROE of -0.05%. Regarding short-term risk, DLB is less volatile compared to SIFY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SIFY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, EFOR has a market cap of 960M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while EFOR trades at $23.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas EFOR's P/E ratio is 5.42. In terms of profitability, DLB's ROE is +0.09%, compared to EFOR's ROE of +0.05%. Regarding short-term risk, DLB is less volatile compared to EFOR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check EFOR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, ASGN has a market cap of 895M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while ASGN trades at $20.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas ASGN's P/E ratio is 9.32. In terms of profitability, DLB's ROE is +0.09%, compared to ASGN's ROE of +0.05%. Regarding short-term risk, DLB is less volatile compared to ASGN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ASGN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, SLAI has a market cap of 880.1M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while SLAI trades at $3.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas SLAI's P/E ratio is -1.40. In terms of profitability, DLB's ROE is +0.09%, compared to SLAI's ROE of -0.83%. Regarding short-term risk, DLB is less volatile compared to SLAI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SLAI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, BBAI-WT has a market cap of 863.4M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while BBAI-WT trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas BBAI-WT's P/E ratio is -0.20. In terms of profitability, DLB's ROE is +0.09%, compared to BBAI-WT's ROE of -0.51%. Regarding short-term risk, DLB is less volatile compared to BBAI-WT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BBAI-WT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, MGIC has a market cap of 853.3M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while MGIC trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas MGIC's P/E ratio is 21.20. In terms of profitability, DLB's ROE is +0.09%, compared to MGIC's ROE of +0.11%. Regarding short-term risk, DLB is more volatile compared to MGIC. This indicates higher risk in terms of short-term price fluctuations for DLB.Check MGIC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, NABL has a market cap of 844.9M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while NABL trades at $4.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas NABL's P/E ratio is 11.50. In terms of profitability, DLB's ROE is +0.09%, compared to NABL's ROE of -0.01%. Regarding short-term risk, DLB is less volatile compared to NABL. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NABL's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CTLP has a market cap of 825.8M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CTLP trades at $11.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CTLP's P/E ratio is 280.00. In terms of profitability, DLB's ROE is +0.09%, compared to CTLP's ROE of +0.01%. Regarding short-term risk, DLB is more volatile compared to CTLP. This indicates higher risk in terms of short-term price fluctuations for DLB.Check CTLP's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, WYFI has a market cap of 794.7M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while WYFI trades at $20.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas WYFI's P/E ratio is -12.22. In terms of profitability, DLB's ROE is +0.09%, compared to WYFI's ROE of -0.12%. Regarding short-term risk, DLB is less volatile compared to WYFI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check WYFI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, VRRM has a market cap of 774.7M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while VRRM trades at $5.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas VRRM's P/E ratio is 4.05. In terms of profitability, DLB's ROE is +0.09%, compared to VRRM's ROE of +0.40%. Regarding short-term risk, DLB is less volatile compared to VRRM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check VRRM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CLVT-PA has a market cap of 755.5M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CLVT-PA trades at $4.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CLVT-PA's P/E ratio is -7.93. In terms of profitability, DLB's ROE is +0.09%, compared to CLVT-PA's ROE of -0.03%. Regarding short-term risk, DLB is less volatile compared to CLVT-PA. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CLVT-PA's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, HIVE has a market cap of 677.9M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while HIVE trades at $2.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas HIVE's P/E ratio is -3.43. In terms of profitability, DLB's ROE is +0.09%, compared to HIVE's ROE of -0.26%. Regarding short-term risk, DLB is less volatile compared to HIVE. This indicates lower risk in terms of short-term price fluctuations for DLB.Check HIVE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, PHLT has a market cap of 611.6M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while PHLT trades at $7.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas PHLT's P/E ratio is -775.00. In terms of profitability, DLB's ROE is +0.09%, compared to PHLT's ROE of +0.02%. Regarding short-term risk, DLB is more volatile compared to PHLT. This indicates higher risk in terms of short-term price fluctuations for DLB.Check PHLT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, TASK has a market cap of 585.5M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while TASK trades at $6.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas TASK's P/E ratio is 4.06. In terms of profitability, DLB's ROE is +0.09%, compared to TASK's ROE of +0.21%. Regarding short-term risk, DLB is less volatile compared to TASK. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TASK's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, GDYN has a market cap of 568.7M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while GDYN trades at $6.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas GDYN's P/E ratio is 17.89. In terms of profitability, DLB's ROE is +0.09%, compared to GDYN's ROE of +0.01%. Regarding short-term risk, DLB is less volatile compared to GDYN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GDYN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, ALIT has a market cap of 534.7M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while ALIT trades at $20.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas ALIT's P/E ratio is 12.69. In terms of profitability, DLB's ROE is +0.09%, compared to ALIT's ROE of -1.72%. Regarding short-term risk, DLB is less volatile compared to ALIT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ALIT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, IBEX has a market cap of 489M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while IBEX trades at $36.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas IBEX's P/E ratio is 10.29. In terms of profitability, DLB's ROE is +0.09%, compared to IBEX's ROE of +0.32%. Regarding short-term risk, DLB is less volatile compared to IBEX. This indicates lower risk in terms of short-term price fluctuations for DLB.Check IBEX's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, PSFE has a market cap of 446M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while PSFE trades at $8.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas PSFE's P/E ratio is 4.25. In terms of profitability, DLB's ROE is +0.09%, compared to PSFE's ROE of -0.29%. Regarding short-term risk, DLB is less volatile compared to PSFE. This indicates lower risk in terms of short-term price fluctuations for DLB.Check PSFE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, SHAZ has a market cap of 392.5M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while SHAZ trades at $40.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas SHAZ's P/E ratio is -9.37. In terms of profitability, DLB's ROE is +0.09%, compared to SHAZ's ROE of -1.78%. Regarding short-term risk, DLB is less volatile compared to SHAZ. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SHAZ's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, XRX has a market cap of 345.3M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while XRX trades at $2.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas XRX's P/E ratio is -2.72. In terms of profitability, DLB's ROE is +0.09%, compared to XRX's ROE of -1.35%. Regarding short-term risk, DLB is less volatile compared to XRX. This indicates lower risk in terms of short-term price fluctuations for DLB.Check XRX's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, TLS has a market cap of 330.7M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while TLS trades at $4.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas TLS's P/E ratio is 24.56. In terms of profitability, DLB's ROE is +0.09%, compared to TLS's ROE of -0.24%. Regarding short-term risk, DLB is less volatile compared to TLS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TLS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, HCKT has a market cap of 281.4M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while HCKT trades at $11.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas HCKT's P/E ratio is 7.50. In terms of profitability, DLB's ROE is +0.09%, compared to HCKT's ROE of +0.16%. Regarding short-term risk, DLB is less volatile compared to HCKT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check HCKT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, BULLZ has a market cap of 260.4M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while BULLZ trades at $1.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas BULLZ's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to BULLZ's ROE of -0.01%. Regarding short-term risk, DLB is less volatile compared to BULLZ. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BULLZ's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, UIS has a market cap of 253.7M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while UIS trades at $3.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas UIS's P/E ratio is 4.19. In terms of profitability, DLB's ROE is +0.09%, compared to UIS's ROE of +1.25%. Regarding short-term risk, DLB is less volatile compared to UIS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check UIS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CNDT has a market cap of 252.8M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CNDT trades at $1.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CNDT's P/E ratio is -4.29. In terms of profitability, DLB's ROE is +0.09%, compared to CNDT's ROE of -0.20%. Regarding short-term risk, DLB is less volatile compared to CNDT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CNDT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, TSSI has a market cap of 243.1M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while TSSI trades at $8.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas TSSI's P/E ratio is 17.67. In terms of profitability, DLB's ROE is +0.09%, compared to TSSI's ROE of +0.25%. Regarding short-term risk, DLB is less volatile compared to TSSI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TSSI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, III has a market cap of 203.8M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while III trades at $4.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas III's P/E ratio is 12.53. In terms of profitability, DLB's ROE is +0.09%, compared to III's ROE of +0.11%. Regarding short-term risk, DLB is less volatile compared to III. This indicates lower risk in terms of short-term price fluctuations for DLB.Check III's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, XRXDW has a market cap of 191M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while XRXDW trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas XRXDW's P/E ratio is -0.46. In terms of profitability, DLB's ROE is +0.09%, compared to XRXDW's ROE of -1.35%. Regarding short-term risk, DLB is less volatile compared to XRXDW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check XRXDW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, SRT has a market cap of 178.3M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while SRT trades at $4.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas SRT's P/E ratio is -6.60. In terms of profitability, DLB's ROE is +0.09%, compared to SRT's ROE of -0.00%. Regarding short-term risk, DLB is more volatile compared to SRT. This indicates higher risk in terms of short-term price fluctuations for DLB.Check SRT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CTG has a market cap of 169M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CTG trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CTG's P/E ratio is 350.00. In terms of profitability, DLB's ROE is +0.09%, compared to CTG's ROE of +0.07%. Regarding short-term risk, DLB is more volatile compared to CTG. This indicates higher risk in terms of short-term price fluctuations for DLB.Check CTG's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, KORE has a market cap of 163M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while KORE trades at $9.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas KORE's P/E ratio is -4.97. In terms of profitability, DLB's ROE is +0.09%, compared to KORE's ROE of +0.48%. Regarding short-term risk, DLB is more volatile compared to KORE. This indicates higher risk in terms of short-term price fluctuations for DLB.Check KORE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, TTEC has a market cap of 123.6M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while TTEC trades at $2.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas TTEC's P/E ratio is 2.65. In terms of profitability, DLB's ROE is +0.09%, compared to TTEC's ROE of -1.12%. Regarding short-term risk, DLB is less volatile compared to TTEC. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TTEC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, ALYA has a market cap of 110.3M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while ALYA trades at $1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas ALYA's P/E ratio is -3.42. In terms of profitability, DLB's ROE is +0.09%, compared to ALYA's ROE of -0.09%. Regarding short-term risk, DLB is less volatile compared to ALYA. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ALYA's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, WYY has a market cap of 96.7M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while WYY trades at $9.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas WYY's P/E ratio is -48.90. In terms of profitability, DLB's ROE is +0.09%, compared to WYY's ROE of -0.16%. Regarding short-term risk, DLB is less volatile compared to WYY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check WYY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CSPI has a market cap of 79.7M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CSPI trades at $7.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CSPI's P/E ratio is -791.00. In terms of profitability, DLB's ROE is +0.09%, compared to CSPI's ROE of -0.00%. Regarding short-term risk, DLB is less volatile compared to CSPI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CSPI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CHRN has a market cap of 66M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CHRN trades at $18.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CHRN's P/E ratio is -3.60. In terms of profitability, DLB's ROE is +0.09%, compared to CHRN's ROE of N/A. Regarding short-term risk, DLB is less volatile compared to CHRN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CHRN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CTM has a market cap of 62.9M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CTM trades at $0.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CTM's P/E ratio is -50.81. In terms of profitability, DLB's ROE is +0.09%, compared to CTM's ROE of -0.05%. Regarding short-term risk, DLB is less volatile compared to CTM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CTM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, QXL has a market cap of 56.1M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while QXL trades at $4.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas QXL's P/E ratio is -84.20. In terms of profitability, DLB's ROE is +0.09%, compared to QXL's ROE of -1.77%. Regarding short-term risk, DLB is less volatile compared to QXL. This indicates lower risk in terms of short-term price fluctuations for DLB.Check QXL's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, USIO has a market cap of 54.4M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while USIO trades at $1.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas USIO's P/E ratio is -26.06. In terms of profitability, DLB's ROE is +0.09%, compared to USIO's ROE of -0.12%. Regarding short-term risk, DLB is less volatile compared to USIO. This indicates lower risk in terms of short-term price fluctuations for DLB.Check USIO's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, SIFYR has a market cap of 44.3M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while SIFYR trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas SIFYR's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to SIFYR's ROE of N/A. Regarding short-term risk, DLB is less volatile compared to SIFYR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SIFYR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, SAIH has a market cap of 35.3M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while SAIH trades at $19.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas SAIH's P/E ratio is -3.50. In terms of profitability, DLB's ROE is +0.09%, compared to SAIH's ROE of -0.68%. Regarding short-term risk, DLB is less volatile compared to SAIH. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SAIH's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, JFU has a market cap of 30M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while JFU trades at $2.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas JFU's P/E ratio is 547.19. In terms of profitability, DLB's ROE is +0.09%, compared to JFU's ROE of +0.04%. Regarding short-term risk, DLB is more volatile compared to JFU. This indicates higher risk in terms of short-term price fluctuations for DLB.Check JFU's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CLPS has a market cap of 26M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CLPS trades at $0.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CLPS's P/E ratio is -3.67. In terms of profitability, DLB's ROE is +0.09%, compared to CLPS's ROE of -0.12%. Regarding short-term risk, DLB is less volatile compared to CLPS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CLPS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, AERTW has a market cap of 22.5M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while AERTW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas AERTW's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to AERTW's ROE of -0.89%. Regarding short-term risk, DLB is more volatile compared to AERTW. This indicates higher risk in terms of short-term price fluctuations for DLB.Check AERTW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, DTST has a market cap of 18.9M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while DTST trades at $2.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas DTST's P/E ratio is 43.14. In terms of profitability, DLB's ROE is +0.09%, compared to DTST's ROE of +0.65%. Regarding short-term risk, DLB is less volatile compared to DTST. This indicates lower risk in terms of short-term price fluctuations for DLB.Check DTST's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, CHOW has a market cap of 12.4M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while CHOW trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas CHOW's P/E ratio is -3.89. In terms of profitability, DLB's ROE is +0.09%, compared to CHOW's ROE of -0.58%. Regarding short-term risk, DLB is less volatile compared to CHOW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CHOW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, SGLB has a market cap of 11.3M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while SGLB trades at $1.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas SGLB's P/E ratio is -1.37. In terms of profitability, DLB's ROE is +0.09%, compared to SGLB's ROE of -2.65%. Regarding short-term risk, DLB is less volatile compared to SGLB. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SGLB's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, TDTH has a market cap of 10.6M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while TDTH trades at $2.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas TDTH's P/E ratio is -0.38. In terms of profitability, DLB's ROE is +0.09%, compared to TDTH's ROE of +3.18%. Regarding short-term risk, DLB is less volatile compared to TDTH. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TDTH's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, ENRDW has a market cap of 10.1M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while ENRDW trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas ENRDW's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to ENRDW's ROE of N/A. Regarding short-term risk, DLB is less volatile compared to ENRDW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ENRDW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, LZMH has a market cap of 9.9M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while LZMH trades at $1.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas LZMH's P/E ratio is -0.38. In terms of profitability, DLB's ROE is +0.09%, compared to LZMH's ROE of -3.05%. Regarding short-term risk, DLB is less volatile compared to LZMH. This indicates lower risk in terms of short-term price fluctuations for DLB.Check LZMH's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, LHSW has a market cap of 8.9M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while LHSW trades at $2.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas LHSW's P/E ratio is -22.83. In terms of profitability, DLB's ROE is +0.09%, compared to LHSW's ROE of +0.32%. Regarding short-term risk, DLB is less volatile compared to LHSW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check LHSW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, VEEA has a market cap of 8.6M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while VEEA trades at $0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas VEEA's P/E ratio is -1.95. In terms of profitability, DLB's ROE is +0.09%, compared to VEEA's ROE of +3.14%. Regarding short-term risk, DLB is less volatile compared to VEEA. This indicates lower risk in terms of short-term price fluctuations for DLB.Check VEEA's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, VEEAW has a market cap of 8.2M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while VEEAW trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas VEEAW's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to VEEAW's ROE of +3.14%. Regarding short-term risk, DLB is less volatile compared to VEEAW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check VEEAW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 5B. In comparison, GLE has a market cap of 7.8M. Regarding current trading prices, DLB is priced at $52.54 on the NYSE, while GLE trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 12.51, whereas GLE's P/E ratio is -4.87. In terms of profitability, DLB's ROE is +0.09%, compared to GLE's ROE of +0.20%. Regarding short-term risk, DLB is less volatile compared to GLE. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GLE's competition here